Fetal Cardiac Functions in Fasting Pregnant Women
Evaluation of Fetal Cardiac Functions in Fasting Pregnant Women
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Sanliurfa, Turkey (Türkiye), 63100
- Sanliurfa Education and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Singleton, uncomplicated pregnancies that have been fasting for at least the last 10 days
- Present for routine antenatal follow-up between 24-34 weeks of gestation
Exclusion Criteria:
- Multiple pregnancy
- Premature rupture of membranes
- Chorioamnionitis
- Placental abruption
- Severe fetal growth restriction
- Congenital fetal anomalies
- Preeclampsia
- Oligohydramnios
- Maternal diabetes -Conditions where fasting is contraindicated for the mother. -
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Singleton uncomplicated pregnancies with at least 10 days of fasting.
|
All singleton uncomplicated pregnancies that present to our hospital for routine antenatal follow-up between 24-34 weeks of gestation will be included in this study.
|
|
The control group will consist of healthy pregnant women who do not fast, with singleton uncomplicat
|
All singleton uncomplicated pregnancies that present to our hospital for routine antenatal follow-up between 24-34 weeks of gestation will be included in this study.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Singleton uncomplicated pregnancies with at least 10 days of fasting.
Time Frame: Fetal echocardiographic findings after at least 10 days of fasting.
|
Fetal echocardiographic findings after at least 10 days of fasting.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ŞEAH/fasting card
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.